美股短线交易员2020-05-08 05:37
$Lipocine(LPCN)$ 冲量有起色,财报一般但新药申请提交了,现金可以维持到2021年2月,总体看涨,利好都已经PRICE IN了,稍微买点看看
查看全文
美股律师郝俊波2020-01-08 13:14
$Lipocine(LPCN)$ Lipocine Inc(NASDAQ: LPCN)因证券欺诈案已经于近日被投资者诉至法院。如果您投资该证券受损,请点击我们的雪球网相关集体诉讼专题页:网页链接查看全文
$Lipocine(LPCN)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001493152-24-014273 Act: 34 Size: 6 MB 网页链接
$Lipocine(LPCN)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001493152-24-011600 Act: 34 Size: 290 KB 网页链接
$Lipocine(LPCN)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001493152-24-011053 Act: 34 Size: 261 KB 网页链接
$Lipocine(LPCN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-009705 Size: 4 KB 网页链接
$Lipocine(LPCN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-009707 Size: 4 KB 网页链接
$Lipocine(LPCN)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001493152-24-009283 Act: 34 Size: 14 MB 网页链接
$Lipocine(LPCN)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001493152-24-009127 Act: 34 Size: 9 MB 网页链接
$Lipocine(LPCN)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001493152-24-009128 Act: 34 Size: 406 KB 网页链接
$Lipocine(LPCN)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001493152-24-008925 Act: 34 Size: 256 KB 网页链接
$Lipocine(LPCN)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001493152-24-005897 Act: 34 Size: 256 KB 网页链接